Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
3.880
-0.140 (-3.48%)
Mar 10, 2026, 4:00 PM EDT - Market closed
Alvotech Market Cap
Alvotech has a market cap or net worth of $1.21 billion as of March 10, 2026. Its market cap has decreased by -67.21% in one year.
Market Cap
1.21B
Enterprise Value
2.45B
1-Year Change
-67.21%
Ranking
Category
Stock Price
$3.88
Market Cap Chart
Since November 9, 2020, Alvotech's market cap has increased from $304.69M to $1.21B, an increase of 298.61%. That is a compound annual growth rate of 29.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 1.26B | -21.64% |
| Dec 31, 2025 | 1.61B | -59.76% |
| Dec 31, 2024 | 3.99B | 30.92% |
| Dec 29, 2023 | 3.05B | 22.59% |
| Dec 30, 2022 | 2.49B | 705.34% |
| Dec 31, 2021 | 308.75M | -5.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amylyx Pharmaceuticals | 1.58B |
| ANI Pharmaceuticals | 1.56B |
| Perrigo Company | 1.42B |
| Harrow | 1.31B |
| Collegium Pharmaceutical | 1.18B |
| Evotec SE | 1.08B |
| Cronos Group | 958.27M |
| Pacira BioSciences | 900.50M |